Bioequivalence question
From: "Bonate, Peter, HMR/US" <Peter.Bonate@hmrag.com>
Subject: Bioequivalence question
Date: Fri, 13 Nov 1998 12:16:37 -0600
Does anyone know what the scientific basis for the 80/125 rule in bioequivalence was? Are there any references that discuss why this particular rule was selected?
PETER L. BONATE, PhD.
Population Pharmacokinetics
Hoechst Marion Roussel
POB 9627 (F4-M3112)
Kansas City, MO 64134
phone: 816-966-3723
fax: 816-966-6999